Drug Database · Clinicians

Brompheniramine

Brands (1) BromphenovaShow all

US brand (reference label): Dimetapp Cold and Allergy; not a Philippine-registered brand.

Antihistamine PH FDA category

OTC · Over-the-counter1 PH product
Dispensing: Over-the-counter (OTC) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 15c3570c-bd00-8e43-e063-6294a90a8683, version date June 1, 2024 (Dimetapp Cold and Allergy · Foundation Consumer Healthcare). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Uses temporarily relieves: runny nose sneezing itching of the nose or throat itchy, watery eyes due to hay fever
US FDA label
Full indications and usage US FDA label

Uses temporarily relieves: runny nose sneezing itching of the nose or throat itchy, watery eyes due to hay fever

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions do not take more than 6 doses in any 24-hour period measure only with dosage cup provided keep dosage cup with product mL = milliliter age dose adults and children 12 years and over 20 mL every 4 hours children 6 to under 12 years 10 mL every 4 hours children under 6 years do not use

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Syrup: 2 mg per 5 mL

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Brompheniramine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Brompheniramine
Package insert
BromphenovaBrompheniramine
2mg per 5 mL SyrupAmber Bottle x 60mL (Box of l’s)
OTC
T. Man Pharma Company LimitedThailand
Medinova Pharmaceutical Inc.
DRP-12425
Aug 5, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Warnings Do not use to sedate a child or to make a child sleepy Ask a doctor before use if you have trouble urinating due to an enlarged prostate gland glaucoma a breathing problem such as emphysema, asthma, or chronic bronchitis Ask a doctor or pharmacist before use if you are taking any other oral nasal decongestant or stimulant taking sedatives or tranquilizers When using this product do not use more than directed drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery excitability may occur, especially in children If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Dimetapp Cold and Allergy · Foundation Consumer Healthcare [US FDA-approved label, version 1, June 1, 2024]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15c3570c-bd00-8e43-e063-6294a90a8683
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .